Vivos (RDGL) Change in Accured Expenses (2010 - 2025)
Vivos' (RDGL) quarterly Change in Accured Expenses came in at -$20221.0 in Q4 2025, down 154.08% year-over-year from $37389.0 in Q4 2024, and down 224.55% quarter-over-quarter from $16235.0 in Q3 2025.
Powered by 
Analysis
Vivos (RDGL) Change in Accured Expenses (2010 - 2025) Analysis & Trends
Vivos has disclosed Change in Accured Expenses across 16 years of filings, most recently posting -$20221.0 for Q4 2025.
- In Q4 2025, Change in Accured Expenses fell 154.08% year-over-year to -$20221.0; the TTM figure through Dec 2025 stood at $6263.0 (up 103.94% YoY), while the FY2025 annual figure was $6263.0, up 103.94% from the prior year.
- Change in Accured Expenses came in at -$20221.0 for Q4 2025 at Vivos, down from $16235.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $176085.0 in Q4 2023 to a low of -$170238.0 in Q1 2024.
- Average Change in Accured Expenses over 5 years is -$850.33, with a median of -$10169.5 recorded in 2022.
- Year-over-year, Change in Accured Expenses soared 322.16% in 2023 and slumped 662.52% in 2024.
- Over 5 years, Change in Accured Expenses stood at -$90353.0 in 2021, then grew by 12.28% to -$79261.0 in 2022, then surged by 322.16% to $176085.0 in 2023, then plunged by 78.77% to $37389.0 in 2024, then sank by 154.08% to -$20221.0 in 2025.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were -$20221.0 in Q4 2025, $16235.0 in Q3 2025, and -$18920.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 55.00 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -531.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 298.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 234.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 123.70 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -74.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 112.90 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Vivos | 23.21 Mn | 23.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -20,221.00 |
| Sep 30, 2025 | 16,235.00 |
| Jun 30, 2025 | -18,920.00 |
| Mar 31, 2025 | 29,169.00 |
| Dec 31, 2024 | 37,389.00 |
| Sep 30, 2024 | -117,740.00 |
| Jun 30, 2024 | 91,794.00 |
| Mar 31, 2024 | -170,238.00 |
| Dec 31, 2023 | 176,085.00 |
| Sep 30, 2023 | -15,441.00 |
| Jun 30, 2023 | 63,821.00 |
| Mar 31, 2023 | -32,703.00 |
| Dec 31, 2022 | -79,261.00 |
| Sep 30, 2022 | -4,898.00 |
| Jun 30, 2022 | 129,578.00 |
| Mar 31, 2022 | -33,812.00 |
| Jun 30, 2021 | -90,353.00 |
| Mar 31, 2021 | 24,210.00 |
| Dec 31, 2020 | -15,603.00 |
| Sep 30, 2020 | -37,274.00 |